The European Asthma Research and Innovation Partnership (EARIP) aims to reduce asthma deaths in Europe by 25% within ten years and by 50% within 20 years. The partnership, made up of 12 European-based organisations, also aims to halve hospital admission rates, speed up the discovery of new treatments and improve self-management. The EARIP project will do this through identifying key gaps in asthma knowledge; it will then address these using a pioneering and integrated approach to research, development and innovation across Europe. Through rapid dissemination of project results, EARIP will ensure that outcomes from knowledge-based asthma research will quickly result in an improved quality of life for people with asthma.
Recent Posts
- An exploration of how online media portrays asthma and its treatment in New Zealand
- Questionnaire Survey for Asthma Remission
- Efficacy evaluation of allergen-specific immunotherapy in children with asthma: a systematic review and meta-analysis
- Monitoring respiratory function with telemedicine devices in asthmatic children
- Can measures of small airway dysfunction aid with the diagnosis or management of asthma exacerbations? A systematic review